Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments: 2022-2025

Historic Change in Acquisitions & Divestments for Whitehawk Therapeutics (WHWK) over the last 3 years, with Sep 2025 value amounting to $2.0 million.

  • Whitehawk Therapeutics' Change in Acquisitions & Divestments fell 86.86% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 51.16%. This contributed to the annual value of $63.3 million for FY2024, which is 58.23% down from last year.
  • According to the latest figures from Q3 2025, Whitehawk Therapeutics' Change in Acquisitions & Divestments is $2.0 million, which was down 41.06% from $3.4 million recorded in Q2 2025.
  • Whitehawk Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $51.2 million during Q2 2023, with a 5-year trough of $2.0 million in Q3 2025.
  • Its 3-year average for Change in Acquisitions & Divestments is $21.4 million, with a median of $15.9 million in 2024.
  • In the last 5 years, Whitehawk Therapeutics' Change in Acquisitions & Divestments surged by 44.02% in 2023 and then slumped by 86.86% in 2025.
  • Over the past 4 years, Whitehawk Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $12.8 million in 2022, then surged by 44.02% to $18.4 million in 2023, then dropped by 27.47% to $13.3 million in 2024, then slumped by 86.86% to $2.0 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $2.0 million for Q3 2025, versus $3.4 million for Q2 2025 and $14.7 million for Q1 2025.